PATENT CLAIM ANALYSIS

Application Number: 16177571
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "121000"]

Abstract:
An aqueous ophthalmic composition for treating ocular disorders, such as macular degeneration and retinopathy, includes Timolol Maleate at a concentration of about 0.1% to 0.5%, Dorzolamide at a concentration of about 0.5% to 2.5%, Prednisolone Sodium Phosphate at a concentration of about 1.0% to 3.0%, Ketorolac Tromethamine at a concentration of about 0.4% to 1.2%, and sterile water at a concentration of at least about 90.0%.

Claim (Index 12):
The composition according to  claim 11 , wherein said Prednisolone Sodium Phosphate is at a concentration of about 1.0% to 3.0% in an aqueous solution.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 1.90698
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15086485', '11594428', '13305391', '13897070', '14671538']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8026617989881061
- 35 USC 102 Novelty (BERT): 0.5094244586789528
- Combined Prediction Score: 0.7733380649571908
- Mean Citation Score: 259.438478
- Max Citation Score: 264.90103
- Similarity Product: 179.23092618798137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test